Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 1
1966 1
1967 1
1972 2
1974 1
1977 1
1986 2
1989 2
1990 4
1991 7
1993 3
1995 1
1996 3
1997 1
1998 1
1999 1
2000 2
2001 2
2002 5
2003 8
2004 2
2005 3
2006 7
2007 3
2008 2
2011 4
2012 3
2013 5
2014 5
2015 4
2016 9
2017 7
2018 4
2020 3
2021 3
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
Potential role of immunotherapy for advanced breast cancer.
de Mello RA, Amaral GA, Tajima CC, Tadokoro H, Iavelberg J, Simonetti D, Tolia M, Silva JA. de Mello RA, et al. Among authors: tadokoro h. Immunotherapy. 2021 Jun;13(8):633-636. doi: 10.2217/imt-2021-0037. Epub 2021 Apr 7. Immunotherapy. 2021. PMID: 33823677 No abstract available.
Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance.
Sato S, Hiruma T, Koizumi M, Yoshihara M, Nakamura Y, Tadokoro H, Motomatsu S, Yamanaka T, Washimi K, Okubo Y, Yoshioka E, Kasajima R, Yamashita T, Kishida T, Yokose T, Miyagi Y. Sato S, et al. Among authors: tadokoro h. Cancer Sci. 2023 Jun;114(6):2674-2688. doi: 10.1111/cas.15786. Epub 2023 Mar 28. Cancer Sci. 2023. PMID: 36916999 Free PMC article.
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer.
De Mello RA, Liu DJ, Aguiar PN, Tadokoro H. De Mello RA, et al. Among authors: tadokoro h. Recent Pat Anticancer Drug Discov. 2016;11(4):393-400. doi: 10.2174/1574892811666160803090944. Recent Pat Anticancer Drug Discov. 2016. PMID: 27491402 Review.
119 results